New sensor could spot newborn infections before they turn deadly
NCT ID NCT03117907
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 68 newborns to see if a non-invasive light sensor, which measures blood flow under the skin (called perfusion index), could help spot infections early. Newborn infections are hard to detect because signs are subtle, and delays can be dangerous. The researchers compared the sensor readings between infected and non-infected babies to see if the sensor could tell them apart.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, non-invasive way to spot infections in newborns earlier, potentially saving lives.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not be strong enough to change practice without larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
68 people
The number who actually took part.
- Started
-
Mar 2016
- Finished
-
Sep 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Newborn of corrected age between 27 SA and 42 SA with at least 72 hours of postnatal age
- Ages
-
27 to 42 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newborn of corrected age between 27 SA and 42 SA with at least 72 hours of postnatal age * Presence of clinical or biological criteria of infection according to CDC definitions * Absence of clinical or biological criteria for infection according to CDC definitions Exclusion Criteria: * Congenital malformation neurological, cardiac, respiratory, vascular and cutaneous. * A proven episode of materno-fetal infection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Clotting clues: simple blood test eyed to catch sepsis before it turns deadly
- Can music soothe premature babies during painful eye exams?
- Can a simple blood test predict sepsis two days early?
- Switching stomach drugs after transplant may tame a deadly immune attack
- Can telemedicine bring IV antibiotics home?
- Lullaby or Mother's voice: a new weapon against newborn pain?